Clinical Trial: A Study of AK157D1 for Injection in Advanced Solid Tumors

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07847281) titled 'A Study of AK157D1 for Injection in Advanced Solid Tumors' on Sept. 21.

Brief Summary: This is an first-in-human, Phase I clinical study aimed at evaluating the safety, tolerability, PK, immunogenicity, and preliminary antitumor efficacy of AK157D1 for injection in advanced solid tumors.

Study Start Date: Sept. 21

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: AK157D1 for injection

IV infusion, administered on Day 1 of each cycle, Q3W, continuous treatment

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Akeso

Published by HT Digital Content Services with permission from Health Daily Digest...